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Evaluation of the Neonatal Sequential Organ Failure Assessment
and Mortality Risk in Preterm Infants With Late-Onset Infection
Noa Fleiss, MD; Sarah A. Coggins, MD; Angela N. Lewis, MD; Angela Zeigler, MD; Krista E. Cooksey, BA; L. Anne Walker, BA; Ameena N. Husain, DO;
Brenda S. de Jong, BSc; Aaron Wallman-Stokes, MD; Mhd Wael Alrifai, MD; Douwe H. Visser, MD, PhD; Misty Good, MD; Brynne Sullivan, MD;
Richard A. Polin, MD; Camilia R. Martin, MD; James L. Wynn, MD

Abstract
IMPORTANCE Infection in neonates remains a substantial problem. Advances for this population
are hindered by the absence of a consensus definition for sepsis. In adults, the Sequential Organ
Failure Assessment (SOFA) operationalizes mortality risk with infection and defines sepsis. The
generalizability of the neonatal SOFA (nSOFA) for neonatal late-onset infection-related mortality
remains unknown.

Key Points
Question How useful is the neonatal
Sequential Organ Failure Assessment for
identification of preterm infants at high
risk for late-onset, infection-associated
mortality?
Findings In this multicenter cohort

OBJECTIVE To determine the generalizability of the nSOFA for neonatal late-onset infection-related

study of 653 preterm infants with late-

mortality across multiple sites.

onset infection, the neonatal Sequential
Organ Failure Assessment score was

DESIGN, SETTING, AND PARTICIPANTS A multicenter retrospective cohort study was conducted

associated with infection-attributable

at 7 academic neonatal intensive care units between January 1, 2010, and December 31, 2019.

mortality. Analyses stratified by sex or

Participants included 653 preterm (<33 weeks) very low-birth-weight infants.

Gram stain of pathogen class or
restricted to less than 25 weeks’

EXPOSURES Late-onset (>72 hours of life) infection including bacteremia, fungemia, or surgical

completed gestation did not reduce the

peritonitis.

association of the neonatal Sequential
Organ Failure Assessment score with

MAIN OUTCOMES AND MEASURES The primary outcome was late-onset infection episode
mortality. The nSOFA scores from survivors and nonsurvivors with confirmed late-onset infection
were compared at 9 time points (T) preceding and following event onset.

infection-related mortality.
Meaning In a large, multicenter cohort,
the single-center–validated neonatal
Sequential Organ Failure Assessment

RESULTS In the 653 infants who met inclusion criteria, median gestational age was 25.5 weeks
(interquartile range, 24-27 weeks) and median birth weight was 780 g (interquartile range, 638-960
g). A total of 366 infants (56%) were male. Late-onset infection episode mortality occurred in 97

score was associated with mortality risk
with late-onset infection in preterm
infants, implying generalizability.

infants (15%). Area under the receiver operating characteristic curves for mortality in the total cohort
ranged across study centers from 0.71 to 0.95 (T0 hours), 0.77 to 0.96 (T6 hours), and 0.78 to 0.96
(T12 hours), with utility noted at all centers and in aggregate. Using the maximum nSOFA score at T0
or T6, the area under the receiver operating characteristic curve for mortality was 0.88 (95% CI,
0.84-0.91). Analyses stratified by sex or Gram-stain identification of pathogen class or restricted to

+ Supplemental content
Author affiliations and article information are
listed at the end of this article.

infants born at less than 25 weeks’ completed gestation did not reduce the association of the nSOFA
score with infection-related mortality.
CONCLUSIONS AND RELEVANCE The nSOFA score was associated with late-onset infection
mortality in preterm infants at the time of evaluation both in aggregate and in each center. These
findings suggest that the nSOFA may serve as the foundation for a consensus definition of sepsis in
this population.
JAMA Network Open. 2021;4(2):e2036518. doi:10.1001/jamanetworkopen.2020.36518
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Introduction
Although overall survival rates among preterm infants have improved, sepsis remains a significant
factor associated with long-term morbidity and mortality in this population.1-4 Late-onset sepsis
(sepsis that occurs after 72 hours of life during the birth hospitalization) affects 20% to 30% of the
most preterm infants and has a 15% mortality rate.5-10 Despite multiple efforts, the methods of
diagnosis, clinical management, and outcomes for preterm infants with late-onset sepsis have been
largely unchanged over several decades. These findings are in part due to a lack of an accepted
consensus definition for sepsis and a paucity of validated metrics reliably associated with sepsisrelated mortality in this population.11
Consensus definitions are needed (1) for the development of standard research protocols, (2) to
determine sample size, (3) to prevent misclassification of patients, and (4) to facilitate replication
and improvement in future studies. Sepsis is defined as life-threatening organ dysfunction caused by
a dysregulated host response to infection.12 Life-threatening organ dysfunction is substantiated by
a Sequential Organ Failure Assessment (SOFA) score that categorically defines the extent of specific
organ dysfunction that increases the risk of death or intensive care unit (ICU) admission.12,13 In
contrast to adult and pediatric ICU environments, the distinction of infection from sepsis and the
incorporation of organ dysfunction are not widely recognized in the neonatal ICU (NICU). Definitions
of sepsis used in neonatology are mostly predicated on the isolation of bacterial pathogens from
blood and/or the associated length of antimicrobial treatment.5,7 A failure to incorporate the
presence or severity of organ dysfunction in preterm infants with late-onset sepsis prevents
grouping of patients according to severity and mortality risk, which is necessary for advancements in
research and improved outcomes.
The neonatal SOFA (nSOFA) was developed to address the need for a consensus definition for
sepsis applicable to neonates.14 Similar to the adult SOFA and pediatric SOFA, the nSOFA serves as an
operational definition of organ dysfunction that can identify those with a high risk of mortality among
preterm infants with infection. Because there is no consensus definition for neonatal sepsis,11 the
development of the nSOFA was informed by the progression of organ failure among preterm infants
with lethal late-onset bacteremia and then validated in a single-center, retrospective cohort of
preterm (<33 weeks) infants with late-onset bacteremia, fungemia, or intestinal perforation
(included as an irrefutable source of infection).14,15 This validation study reported an association of
higher nSOFA scores with infection-related mortality. With the goal of establishing the nSOFA score
as a criterion for a consensus definition of sepsis in this population, in this study we determined the
generalizability of the nSOFA for neonatal infection-related mortality risk in a multicenter,
retrospective cohort of preterm (<33 weeks), very low-birth-weight (VLBW) infants with late-onset
bacteremia, fungemia, or intestinal perforation.

Methods
Study Design
This multicenter retrospective cohort study measured the prognostic utility of the nSOFA for
neonatal mortality among infants with late-onset infection (bacteremia, fungemia, or intestinal
perforation) cared for in NICUs among 7 academic institutions: Columbia University Irving Medical
Center, New York, New York; Beth Israel Deaconess Medical Center, Boston, Massachusetts;
University of Florida, Gainesville; Vanderbilt University Medical Center, Nashville, Tennessee;
Washington University, St Louis, Missouri; University of Virginia, Charlottesville; and Amsterdam
University Medical Center, Amsterdam, the Netherlands. The study was conducted between January
1, 2010, and December 31, 2019. This study followed the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) reporting guideline for cohort studies. Each institution
received approval for study participation with a waiver of informed consent from its institutional review

JAMA Network Open. 2021;4(2):e2036518. doi:10.1001/jamanetworkopen.2020.36518 (Reprinted)

Downloaded From: https://jamanetwork.com/ by a Washington University - St Louis User on 02/07/2021

February 4, 2021

2/11

JAMA Network Open | Pediatrics

Neonatal Sequential Organ Failure Assessment and Mortality Risk in Preterm Infants With Infection

board because the research was retrospective and data were deidentified; thus, the study involved
no more than minimal risk to participants.

Late-Onset Infection Episode
Because there is no consensus definition for neonatal sepsis,11 we considered a new bacteremic or
fungemic event in an infant aged greater than 72 hours who received 5 or more days of antibiotic
treatment or died before completing at least 5 days of treatment with intention to treat as a lateonset infection (LOI) episode. The onset of the LOI episode was defined as the time of clinician
declaration of suspected infection, herein defined as the time of blood culture acquisition. Late-onset
episodes of surgical peritonitis (perforated bowel associated with necrotizing enterocolitis or
spontaneous intestinal perforation) with negative results of blood cultures were included as an
irrefutable source of infection. Infants with positive blood cultures with organisms that are frequently
considered contaminants, including Bacillus species and Corynebacterium species, were excluded.

Inclusion and Exclusion Criteria
All sites used a standardized set of criteria to independently identify eligible events for inclusion.
Inclusion criteria were new LOI (>72 hours of life) in VLBW, preterm (<33 weeks completed gestation)
infants. Only the first episode of LOI was studied. An absence of antibiotic exposure for 48 hours
before the LOI episode evaluation was required to facilitate characterization of an uninfected
baseline in each patient. Each site abstracted and deidentified consecutive clinical and laboratory
data from their electronic health records for all patients who met the inclusion criteria until a
minimum of 5 patients who died with the LOI episode were identified. The frequency of LOIs as well
as the availability of data at each center resulted in variation in the study period between centers,
which overall ranged from 2010 to 2020. The primary outcome was episode mortality, defined as
death that occurred during ongoing antibiotic therapy for an LOI episode. Birth weight, gestational
age at birth, sex, age at event, pathogen identified, time from culture to death, and the suspected
primary infection site were collected. Clinical data required to calculate the nSOFA score were
collected and included the receipt of intubation and mechanical ventilation, the peripheral oxygen
saturation, the fraction of inspired oxygen to achieve the peripheral oxygen saturation, the most
current platelet count, and any requirement for glucocorticoid, inotropic, or vasoactive drugs.

Application of the nSOFA Score
The nSOFA components and scoring paradigms were modeled after the adult SOFA.12,13 The nSOFA
uses only objective and available clinical standard-of-care data to provide an operational definition of
organ dysfunction that facilitates mortality risk stratification among VLBW infants with unequivocal
LOI (bacteremia or intestinal perforation).14 The nSOFA uses categorical scores (total score range
from 0 [best] to 15 [worst]) to objectively describe dynamic changes in (1) receipt of mechanical
ventilation and oxygen to maintain a physiologic peripheral saturation (score range, 0-8); (2)
inotropic or vasoactive drug support, including the use of corticosteroids for presumed adrenal
insufficiency or catecholamine-resistant shock (score range, 0-4); and (3) the presence and severity
of thrombocytopenia based on the most recent platelet measure (score range, 0-3) (Table 1;
eAppendix in the Supplement).
The nSOFA score was validated in an independent, single-center cohort of infants with LOI.14 In
this multicenter, retrospective study to determine the generalizability of the nSOFA, each center
identified qualifying infants and calculated the nSOFA score at 9 discrete time points, including and
surrounding the LOI episode, using a web-based calculator and data from the electronic health
records. The time the blood sample was drawn from the patient represented time 0 (T0). The time
points that preceded (T minus 48 hours [T-48], T-24, T-12, and T-6) and followed (T plus 6 hours [T6],
T12, T24, and T48) the infection evaluation were based on the progression of organ dysfunction in
previous studies.14,15
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Statistical Analysis
Data were deidentified and analyzed in aggregate as well as by individual center. The nSOFA and
demographic information were compared between infection survivors and nonsurvivors. For all data,
tests of normality were performed before comparisons. For descriptive data comparisons, we used
the Mann-Whitney test for nonparametric continuous data and the χ2 test or Fisher exact test for
categorical data. Nonparametric continuous variables were summarized as medians with quartiles
(25th and 75th percentiles). Categorical variables are presented as percentages. The threshold for
statistical significance was P < .05 for 2-sided tests. Time point–based comparisons of nSOFA scores
between designated groups were made using the Mann-Whitney test because the nSOFA score data
were nonparametric. Area under the receiver operating characteristic curves (AUROCs) for mortality
at designated points based on the nSOFA score were calculated using GraphPad Prism, version 8
(GraphPad Software) and the Wilson/Brown method. Chord diagrams were created to depict
associations between organ dysfunction and mortality. Simple logistic regression generated
estimated vs observed mortality. GraphPad Prism or R, version 3.6.2 (R Foundation for Statistical
Computing) was used for all calculations.

Results
Patients
We identified 653 preterm VLBW infants with LOI with median gestational age 25.5 weeks
(interquartile range [IQR], 24-27 weeks) and median birth weight 780 g (IQR, 638-960 g); 97 infants
(15%) died with the LOI episode (Table 2; eFigure 1 in the Supplement). Of the 653 infants, 366
(56%) were male and 287 (44%) were female. Nonsurvivors were born at significantly lower
gestational age than survivors (median, 25 weeks [IQR, 24-26 weeks] vs 26 weeks [IQR, 24-28
weeks]; P < .001) and infection occurred earlier after birth (median, 13 days [IQR, 7-26 days] vs 16
days [IQR, 9-32 days]; P = .04). Deaths considered to be associated with the LOI episode occurred in
close proximity to the reference blood culture (median, 24 hours to death from reference blood
culture; IQR, 11-78 hours). No statistically significant differences in sex or race were found between
survivors and nonsurvivors. There were significant differences in organism distribution between
survivors and nonsurvivors, with Gram-negative bacteremia occurring more frequently among
nonsurvivors (46% [45 of 97] vs 19% [104 of 556]; P < .001) and gram-positive bacteremia occurring
less frequently among nonsurvivors (31% [30 of 97] vs 70% [388 of 556]; P < .001). Infection site
also differed significantly between survivors and nonsurvivors, with abdominal site infection (with or
without a positive blood culture) occurring more frequently among nonsurvivors (46% [45 of 97] vs
18% [98 of 556]; P < .001). The 5 most commonly isolated bacteria from blood were coagulasenegative Staphylococcus species, Staphylococcus aureus (methicillin-sensitive), Escherichia coli,

Table 1. Neonatal Sequential Organ Failure Assessment (nSOFA) Components and Scoringa
Component
Respiratory score
Criteria
Cardiovascular score
Criteriab

Hematologic score
Criteriac

nSOFA Scores
0

2

4

6

8

Not intubated or intubated,
SpO2/FIO2≥300

Intubated,
SpO2/FIO2<300

Intubated,
SpO2/FIO2<200

Intubated,
SpO2/FIO2<150

Intubated,
SpO2/FIO2<100

0

1

2

3

4

No inotropes and no
systemic corticosteroid
treatment

No inotropes and systemic
corticosteroid treatment

1 inotrope and no systemic
corticosteroid treatment

≥2 inotropes or 1 inotrope
and systemic corticosteroid
treatment

≥2 inotropes and systemic
corticosteroid treatment
NA

0

1

2

3

Platelet count
≥150 × 103

Platelet count
100-149 × 103

Platelet count
<100 × 103

Platelet count
<50 × 103

Abbreviations: FIO2, fraction of inspired oxygen; NA, not applicable; SpO2, oxygen
saturation as measured by pulse oxymetry.

b

Medications considered as inotropic or vasoactive included dopamine, dobutamine,
epinephrine, norepinephrine, vasopressin, milrinone, and phenylephrine.

SI conversion factor: To convert platelet count to ×109/L, multiply by 1.

c

Most recent platelet count available to the clinician.

a

Score range, 0 (best) to 15 (worst).
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Klebsiella pneumoniae, and Streptococcus agalactiae (eTable 1 in the Supplement). The frequency of
late mortality during the birth hospitalization among LOI episode survivors was 4% (23 of 556),
occurred a median of 6.7 weeks after the reference culture (IQR, 3.3-11.6 weeks) at a median age of
9.3 weeks (IQR, 5.1-17.9 weeks), and was most common among infants born extremely preterm
(median, 24 weeks; IQR, 24-27 weeks; mean [SD] birth weight, 677 [183] g) with severe
bronchopulmonary dysplasia (14 of 23 [61%]).

nSOFA Comparisons
Compared with survivors, nonsurvivors had elevated total and individual component nSOFA scores
at all time points evaluated (Figure 1; eFigure 2 in the Supplement). The AUROC for mortality in the
total cohort measured at T0 was 0.81 (95% CI, 0.76-0.85); T6, 0.87 (95% CI, 0.83-0.91); and T12,
0.86 (95% CI, 0.81-0.91) (Figure 1). Center-specific AUROC ranges were 0.71 to 0.95 (T0), 0.77 to
0.96 (T6), and 0.78 to 0.96 (T12), with utility noted at all centers (eTable 2 in the Supplement). Using
the maximum nSOFA score at T0 or T6, the AUROC for mortality was 0.88 (95% CI, 0.84-0.91);
logistic regression identified associations between higher T0 and T6 nSOFA scores and death
(eFigure 3 in the Supplement). The mortality rate among patients with a maximum nSOFA score at
T0 or T6 less than 4 was 2.4% (10 of 423), whereas mortality occurred in 81% of infants with
maximum nSOFA scores at T0 or T6 of greater than or equal to 10. The likelihood ratio for mortality
progressively increased as the nSOFA score increased (2-fold with nSOFA score ⱖ2, 4-fold with score
ⱖ6, 8-fold with score ⱖ8, and 16-fold with score ⱖ10) (eFigure 4 in the Supplement). Mortality risk

Table 2. Demographic Characteristics of the Retrospective Cohort
No. (%)
Characteristic

All patients (n = 653)

Lived (n = 556)

Died (n = 97)

Gestational age, median (IQR), wk

25.5 (24-27)

26.0 (24-28)

25.0 (24-26)

≤24

224 (34)

176 (32)

48 (49)

25-26

214 (33)

178 (32)

36 (37)

27-28

126 (19)

118 (21)

8 (8)

≥29

89 (14)

84 (15)

5 (5)

780 (638-960)

800 (650-994)

680 (550-793)

<750

283 (43)

220 (40)

63 (65)

750-999

225 (34)

198 (36)

27 (28)

≥1000

145 (22)

138 (25)

7 (7)

Male

366 (56)

310 (56)

56 (58)

Female

287 (44)

246 (44)

41 (42)

Black

170 (26)

140 (25)

30 (31)

White

355 (54)

302 (54)

53 (55)

Birth weight, median (IQR), g

P value

<.001a

<.001a

Sex
.94b

Race

Other

128 (20)

114 (21)

14 (14)

16 (9-31)

16 (9-32)

13 (7-26)

Gram-positive

418 (64)

388 (70)

30 (31)

Gram-negative

149 (23)

104 (19)

45 (46)

Fungus

15 (2)

13 (2)

2 (2)

None identified

68 (10)

48 (9)

20 (21)

Event day of life, median (IQR)

.63c
.04a

d

Pathogen

Abbreviations: CLABSI, central line–associated
bloodstream infection; IQR, interquartile range.
<.001c

Primary infection site
Bacteremia/fungemia

336 (51)

303 (54)

33 (34)

Abdomen

143 (22)

98 (18)

45 (46)

CLABSI

33 (5)

26 (5)

7 (7)

30 (5)

27 (5)

3 (3)

111 (17)

102 (18)

9 (9)

Other

e

Undetermined

a

Mann-Whitney test.

b

Fisher exact test.

c

χ2 test.

d

All patients had bacteremia or perforated bowel; 3
patients (all of whom survived) had both grampositive and gram-negative organisms isolated from
blood samples (not listed in the table).

e

Included pulmonary, renal, central nervous system,
and soft-tissue sites.

<.001c
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increased with nSOFA score category at all time points analyzed (eTable 3 in the Supplement).
Because a large portion of LOI episode-related mortality occurred in the most preterm infants, we
performed a subanalysis on infants who had completed less than 25 weeks’ gestation at birth
(n = 224). At all preinfection time points, nSOFA scores were higher among survivors less than 25
weeks compared with those greater than or equal to 25 weeks (median 2 [IQR, 0-4] v 0 [IQR, 0-1]; all
P < .001) (eFigure 5 in the Supplement). Similarly, median nSOFA scores were higher among
nonsurvivors less than 25 weeks compared with those greater than or equal to 25 weeks (T-48, 3
[IQR, 0-6] vs 1 [IQR, 0-4]; T-24, 4 [IQR, 1-8] vs 1 [IQR, 0-4]; T-12, 5 [IQR, 1-8] vs 2 [IQR, 0-4]; T-6, 4
[IQR, 2-8] v 2 [IQR, 0-5]; all P < .05) (eFigure 5 in the Supplement).Differences in nSOFA scores
between infants born at less than 25 weeks of completed gestation who were survivors and
nonsurvivors were present at all time points between groups. AUROCs for mortality in infants born
at less than 25 weeks of gestation were also comparable with results in the total cohort: T0, 0.78
(95% CI, 0.70-0.86); T6, 0.83 (95% CI, 0.76-0.89); and T12, 0.83 (95% CI, 0.77-0.90). The change
in nSOFA scores was most pronounced among nonsurvivors between T-48 and T0 (median, 3; IQR,
0-6), T-24 and T0 (median, 3; IQR, 0-5), and T-6 and T0 (median, 2; IQR, 0-4) (all P < .001) (Figure 2;
eFigure 6 and eFigure 7 in the Supplement). Comparable nSOFA score changes occurred in infants
born at less than 25 weeks’ gestation (eFigure 8 in the Supplement).
Nonsurvivors showed baseline differences as well as a progressive increase in the frequency of
respiratory, cardiovascular, and hematologic dysfunction compared with survivors (eFigure 2 in the
Supplement). Respiratory dysfunction divergence was present as early as T-12. Compared with
survivors, nonsurvivors manifested the greatest divergence in cardiovascular component scores at
T6. Hematologic dysfunction divergence between nonsurvivors and survivors was most pronounced
at T0 and was sustained through T48. Chord diagrams summarize the frequency and extent of organ
dysfunction between survivors and nonsurvivors at each of the 9 time points examined (eFigure 9
in the Supplement).
When survivors and nonsurvivors were compared by sex, no significant differences between
groups at any time point were present (eFigure 10 in the Supplement). Similarly, a comparison of
survivors and nonsurvivors by Gram-stain class isolated from blood revealed comparable trends in
nSOFA with results in the total cohort (eFigure 11 in the Supplement). nSOFA profiles among infants
with a perforated bowel but negative blood cultures showed analogous changes between survivors
and nonsurvivors with results in the total cohort (eFigure 12 in the Supplement). The frequency of
late mortality during the birth hospitalization among LOI survivors in this multicenter study was 4%

Figure 1. Neonatal Sequential Organ Failure Assessment (nSOFA) Scores Among Preterm Survivors and Nonsurvivors With Late-Onset Infection
A All patient values

B

15

Area under receiver operating characteristic curve
(AUROC) for death
100

Survivors
Nonsurvivors

80

Sensitivity, %

nSOFA score

12

9

6

3

60

40
12 h
6h
Baseline

20

0

0
–48

–24

–12

–6

0

6

12

24

48

Timing relative to sepsis evaluation, h

A, All values for survivors (n = 556) and nonsurvivors (n = 97). Violin plots represent
group medians at each time point. Error bars represent interquartile ranges. B, Area
under receiver operating characteristic curve (AUROC) for death shown for T0 (0.81;

0

20

40

60

80

100

Specificity, %

95% CI, 0.76-0.85), T6 (0.87; 95% CI, 0.83-0.91), and T12 (0.86; 95% CI, 0.81-0.91) time
points. All AUROCs: P < .001.
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(23 of 556; median, 6.7 weeks after the reference culture; IQR, 3.3-11.6 weeks; median age, 9.3
weeks; IQR, 5.1-17.9 weeks) and was most common among infants born extremely preterm (median,
24 weeks; IQR, 24-27 weeks; mean [SD] birth weight, 677 [183] g) with severe bronchopulmonary
dysplasia (14 of 23 [61%]).

Figure 2. Change in Neonatal Sequential Organ Failure Assessment (nSOFA) Score With an Infection Episode
Among Survivors and Nonsurvivors
A Change in nSOFA prior to evaluation

15

Survivors
Nonsurvivors

Change in nSOFA

10

5

0

–5

–10
–48 to 0

–24 to 0

–48 to –24
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–12 to –6

–6 to 0

Time before evaluation, h
B

Change in nSOFA after evaluation
15

Change in nSOFA
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5

0

–5
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Time after evaluation, h
C

Peri-evaluation nSOFA differences
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Change in nSOFA

10

5

0

–5

–10
–6 to 6

–12 to 12

–24 to 24

–48 to 48

Time from evaluation, h
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All values for survivors (n = 556) and nonsurvivors
(n = 97). Violin plots represent group medians at each
time point. Error bars represent interquartile ranges
(IQRs). A, Before evaluation, the change in the nSOFA
score was most pronounced among nonsurvivors
between T-48 and T0 (median, 3; IQR, 0-6), T-24 and
T0 (median, 3; IQR, 0-5), and T-6 and T0 (median, 2;
IQR, 0-4); all P < .001. B, Change in the nSOFA score at
postevaluation time points. C, Peri-evaluation nSOFA
score differences increased proportionally to the
length of time interval measured (T-6 to T6: median, 3
(IQR, 1-7); T-12 to T12: median, 4 (IQR, 1-7); T-24 to T24:
median, 5 (IQR, 2-8); and T-48 to T48: median, 7 (IQR,
3-10). For patients who died before a time point
measured, the most recent nSOFA score was used for
calculations.
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Discussion
In adults with suspected infection, the definition of sepsis is based on the presence of lifethreatening organ dysfunction, reflected in the SOFA score, which is associated with ICU admission
or mortality.12 To reach a consensus definition of sepsis in the neonatal population, it is essential to
establish an operational definition of life-threatening organ dysfunction applicable to the preterm
population (nSOFA). Because preterm neonates are not often cared for outside of the NICU, the most
severe outcome (mortality) among those with an infection must be used. The nSOFA, an adaptation
of the SOFA specific to neonates, demonstrated generalizability in aggregate and in each center as a
risk assessment tool that identified LOI-associated mortality risk among VLBW infants in this multicenter cohort study. Taken together, the nSOFA score may serve as a useful criterion on which to
build a consensus definition of sepsis in this population.
A lack of developmental age-specific criteria for life-threatening organ dysfunction applicable
to the preterm population prevents meaningful classification and study of infection as well as other
clinical entities in this population. Infants at the lowest extremes of gestational age are at
disproportionately higher risk for late-onset infection owing to physiologic immaturity as well as
critical illness that requires prolonged NICU hospitalizations.16,17 However, the nSOFA demonstrated
consistent associations with LOI-associated mortality even in the lowest gestational age strata.
Stratified analyses by sex showed negligible differences in the nSOFA performance. Similarly, the
analyses stratified by Gram-stain class of the isolated pathogen showed similar extents of organ
dysfunction among LOI survivors and nonsurvivors.
We identified several relevant parallels of our study with studies on SOFA performance. An
increase in the SOFA score over time (ⱖ2 points) was predictive of mortality risk.18 A systematic
review and meta-regression of SOFA as a predictor of mortality in adults found the change in SOFA
score from baseline to be the metric most reliably associated with mortality19; this finding was
reflected in our study of preterm infants, in which a 2-point increase in the nSOFA score was
associated with a 2-fold increase in the odds of mortality. Similarly, organ dysfunction scores are
widely used as metrics associated with mortality as well as clinical course in pediatric and adult ICU
populations and have been validated across multiple disease states.20-26 No risk of mortality, clinical
course description, or severity of illness scoring paradigms are routinely used in neonatal critical care.
Although life-threatening organ dysfunction is a requirement to distinguish sepsis from infection,
organ dysfunction accompanies multiple disease states that commonly occur in the NICU. As an
objective measure of clinical course, the nSOFA has potential utility as both a surrogate variable for
illness severity and a metric for risk assessment of short- and long-term clinical end points.
We have developed an international consortium of academic centers that have integrated the
nSOFA into their electronic health records for all NICU patients. This consortium may enable nSOFAfocused prospective studies, as well as quality improvement initiatives, aimed at short- and longterm outcomes in the NICU. We do not advocate for use of the nSOFA in clinical practice at this time.
Rather, these data are evidence that the nSOFA can be used to classify mortality risk among preterm
infants with suspected infection for future studies. A precision medicine approach that uses patientspecific stratification of infection mortality risk is needed to establish useful diagnostic testing that
will both facilitate effective antibiotic stewardship and identify those that are most likely to benefit
from potential adjunctive treatments.

Limitations
This study has limitations. The nSOFA scores may have been influenced by institution-specific approaches to care, including variations in thresholds for intubation, corticosteroid or vasopressor use,
and laboratory monitoring. Site-specific analyses revealed negligible effects of intersite variations
across 9 time points in a 96-hour window surrounding the episode. It was not possible to determine
with certainty that the cause of death was secondary to infection alone. To mitigate this potential limitation, we studied only patients with documented bacteremia, fungemia, or a perforated bowel, and all
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deaths considered infection-related occurred in close proximity to the reference culture and while receiving antibiotics for the infection episode evaluated. Taken together, these attributes suggest infection was a significant contributor to mortality. We could not include a focus on meningitis because of a
limited number of documented cases (n = 3), consistent with previous reports in this population indicating that meningitis is rare and frequently associated with bacteremia.27 In contrast to adults and children, who may experience high rates of late mortality (after antimicrobial treatment is completed) following sepsis, the frequency of late mortality during the birth hospitalization among LOI episode survivors in this multicenter study was low, it occurred several weeks after the reference culture, and it was
most common among infants born extremely preterm with severe bronchopulmonary dysplasia. It
could not be determined whether the cause of late mortality was primarily the result of complications
of extreme prematurity, the impact of the previous infection, or a combination of factors. These questions may be answered via study of larger cohorts. This was a study to assess the generalizability of the
nSOFA score in its current iteration. We concede that the score can always be improved as more data
become available. We acknowledge the potential limitation that changes in demographics and standards of care may have occurred over the study period.

Conclusions
Among preterm VLBW infants with confirmed LOI episode, the nSOFA showed generalizable utility
as an operational definition of organ dysfunction associated with mortality risk unaffected by sex,
pathogen, specific center, or extreme prematurity. The nSOFA may provide the requisite foundation
on which to build a consensus definition for sepsis in preterm neonates.

ARTICLE INFORMATION
Accepted for Publication: December 16, 2020.
Published: February 4, 2021. doi:10.1001/jamanetworkopen.2020.36518
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Fleiss N et al.
JAMA Network Open.
Corresponding Author: James L. Wynn, MD, Department of Pediatrics, University of Florida School of Medicine,
1600 SW Archer Rd, PO Box 100296, Gainesville, FL 32610 (james.wynn@peds.ufl.edu).
Author Affiliations: Department of Pediatrics, Columbia University School of Medicine, New York, New York
(Fleiss, Wallman-Stokes, Polin); Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia,
Pennsylvania (Coggins); Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri
(Lewis, Cooksey, Husain, Good); Department of Pediatrics, University of Virginia School of Medicine,
Charlottesville (Zeigler, Sullivan); Department of Pediatrics, Vanderbilt University School of Medicine, Nashville,
Tennessee (Walker, Alrifai); Department of Neonatology, Amsterdam UMC University of Amsterdam, Vrije
Universiteit, Emma Children’s Hospital, Amsterdam, the Netherlands (de Jong, Visser); Department of Pediatrics,
Harvard Medical School, Boston, Massachusetts (Martin); Department of Pediatrics, University of Florida School
of Medicine, Gainesville (Wynn).
Author Contributions: Dr Wynn had full access to all of the data in the study and takes responsibility for the
integrity of the data and the accuracy of the data analysis. Drs Fleiss and Coggins contributed equally to this work.
Concept and design: Coggins, Alrifai, Visser, Polin, Wynn.
Acquisition, analysis, or interpretation of data: Fleiss, Coggins, Lewis, Zeigler, Cooksey, Walker, Husain, de Jong,
Wallman-Stokes, Alrifai, Visser, Good, Sullivan, Martin, Wynn.
Drafting of the manuscript: Fleiss, Coggins, Husain, Wallman-Stokes, Polin, Martin, Wynn.
Critical revision of the manuscript for important intellectual content: Fleiss, Lewis, Zeigler, Cooksey, Walker, de Jong,
Wallman-Stokes, Alrifai, Visser, Good, Sullivan, Martin, Wynn.
Statistical analysis: Fleiss, Coggins, Lewis, Zeigler, de Jong, Martin, Wynn.
Administrative, technical, or material support: Lewis, Zeigler, Cooksey, Alrifai, Visser, Good, Wynn.
Supervision: Alrifai, Polin, Wynn.

JAMA Network Open. 2021;4(2):e2036518. doi:10.1001/jamanetworkopen.2020.36518 (Reprinted)

Downloaded From: https://jamanetwork.com/ by a Washington University - St Louis User on 02/07/2021

February 4, 2021

9/11

JAMA Network Open | Pediatrics

Neonatal Sequential Organ Failure Assessment and Mortality Risk in Preterm Infants With Infection

Conflict of Interest Disclosures: Dr Zeigler reported a grant from the National Heart, Lung, and Blood Institute
during the conduct of the study. Dr Good reported grants from the National Institutes of Health, Children's
Discovery Institute, and from St. Louis Children's Hospital Foundation, other from Takeda Pharmaceuticals, Inc.,
and other from Evive Biotech outside the submitted work. Dr Martin reported grants from Abbott Nutrition, and
Mead Johnson Nutrition, other from LUCA Biologics Scientific Advisory Board, other from Prolacta Biosciences,
and other from Plakous Therapeutics outside the submitted work. Dr Wynn reported grants from the National
Institutes of Health and personal fees from Evolve Biosystems for consulting on the definition of neonatal sepsis
(2019) outside the submitted work. No other disclosures were reported.
Additional Information: The web-based nSOFA calculator used is available at http://www.peds.ufl.edu/apps/nsofa/
default.aspx.
REFERENCES
1. Brocklehurst P, Farrell B, King A, et al; INIS Collaborative Group. Treatment of neonatal sepsis with intravenous
immune globulin. N Engl J Med. 2011;365(13):1201-1211. doi:10.1056/NEJMoa1100441
2. Adams-Chapman I, Heyne RJ, DeMauro SB, et al; Follow-up Study of the Eunice Kennedy Shriver National
Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental impairment
among extremely preterm infants in the Neonatal Research Network. Pediatrics. 2018;141(5):e20173091. doi:10.
1542/peds.2017-3091
3. Rand KM, Austin NC, Inder TE, Bora S, Woodward LJ. Neonatal infection and later neurodevelopmental risk in
the very preterm infant. J Pediatr. 2016;170:97-104. doi:10.1016/j.jpeds.2015.11.017
4. Stoll BJ, Hansen NI, Adams-Chapman I, et al; National Institute of Child Health and Human Development
Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight
infants with neonatal infection. JAMA. 2004;292(19):2357-2365. doi:10.1001/jama.292.19.2357
5. Stoll BJ, Hansen NI, Bell EF, et al; Eunice Kennedy Shriver National Institute of Child Health and Human
Development Neonatal Research Network. Trends in care practices, morbidity, and mortality of extremely preterm
neonates, 1993-2012. JAMA. 2015;314(10):1039-1051. doi:10.1001/jama.2015.10244
6. Tarnow-Mordi W, Morris J, Kirby A, et al; Australian Placental Transfusion Study Collaborative Group. Delayed
versus immediate cord clamping in preterm infants. N Engl J Med. 2017;377(25):2445-2455. doi:10.1056/
NEJMoa1711281
7. ELFIN trial investigators group. Enteral lactoferrin supplementation for very preterm infants: a randomised
placebo-controlled trial. Lancet. 2019;393(10170):423-433. doi:10.1016/S0140-6736(18)32221-9
8. Dorling J, Abbott J, Berrington J, et al; SIFT Investigators Group. Controlled trial of two incremental milk-feeding
rates in preterm infants. N Engl J Med. 2019;381(15):1434-1443. doi:10.1056/NEJMoa1816654
9. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the
NICHD Neonatal Research Network. Pediatrics. 2002;110(2 Pt 1):285-291. doi:10.1542/peds.110.2.285
10. Greenberg RG, Kandefer S, Do BT, et al; Eunice Kennedy Shriver National Institute of Child Health and Human
Development Neonatal Research Network. Late-onset sepsis in extremely premature infants: 2000-2011. Pediatr
Infect Dis J. 2017;36(8):774-779. doi:10.1097/INF.0000000000001570
11. Wynn JL, Wong HR, Shanley TP, Bizzarro MJ, Saiman L, Polin RA. Time for a neonatal-specific consensus
definition for sepsis. Pediatr Crit Care Med. 2014;15(6):523-528. doi:10.1097/PCC.0000000000000157
12. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and
septic shock (Sepsis-3). JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287
13. Matics TJ, Sanchez-Pinto LN. Adaptation and validation of a pediatric Sequential Organ Failure Assessment
score and evaluation of the Sepsis-3 definitions in critically ill children. JAMA Pediatr. 2017;171(10):e172352. doi:10.
1001/jamapediatrics.2017.2352
14. Wynn JL, Polin RA. A neonatal Sequential Organ Failure Assessment score predicts mortality to late-onset
sepsis in preterm very low birth weight infants. Pediatr Res. 2020;88(1):85-90. doi:10.1038/s41390-019-0517-2
15. Wynn JL, Kelly MS, Benjamin DK, et al. Timing of multiorgan dysfunction among hospitalized infants with fatal
fulminant sepsis. Am J Perinatol. 2017;34(7):633-639. doi:10.1055/s-0036-1597130
16. Fanaroff AA, Korones SB, Wright LL, et al; The National Institute of Child Health and Human Development
Neonatal Research Network. Incidence, presenting features, risk factors and significance of late onset septicemia
in very low birth weight infants. Pediatr Infect Dis J. 1998;17(7):593-598. doi:10.1097/00006454199807000-00004
17. Giannoni E, Agyeman PKA, Stocker M, et al. Neonatal sepsis of early onset, and hospital-acquired and
community-acquired late onset: a prospective population-based cohort study. J Pediatr. 2018;201:106-114.e4. doi:10.
1016/j.jpeds.2018.05.048
JAMA Network Open. 2021;4(2):e2036518. doi:10.1001/jamanetworkopen.2020.36518 (Reprinted)

Downloaded From: https://jamanetwork.com/ by a Washington University - St Louis User on 02/07/2021

February 4, 2021

10/11

JAMA Network Open | Pediatrics

Neonatal Sequential Organ Failure Assessment and Mortality Risk in Preterm Infants With Infection

18. Raith EP, Udy AA, Bailey M, et al; Australian and New Zealand Intensive Care Society (ANZICS) Centre for
Outcomes and Resource Evaluation (CORE). Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score
for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA. 2017;
317(3):290-300. doi:10.1001/jama.2016.20328
19. de Grooth HJ, Geenen IL, Girbes AR, Vincent JL, Parienti JJ, Oudemans-van Straaten HM. SOFA and mortality
endpoints in randomized controlled trials: a systematic review and meta-regression analysis. Crit Care. 2017;
21(1):38. doi:10.1186/s13054-017-1609-1
20. Jhang WK, Kim YA, Ha EJ, et al. Extrarenal sequential organ failure assessment score as an outcome predictor
of critically ill children on continuous renal replacement therapy. Pediatr Nephrol. 2014;29(6):1089-1095. doi:10.
1007/s00467-013-2741-z
21. Ha EJ, Kim S, Jin HS, et al. Early changes in SOFA score as a prognostic factor in pediatric oncology patients
requiring mechanical ventilatory support. J Pediatr Hematol Oncol. 2010;32(8):e308-e313. doi:10.1097/MPH.
0b013e3181e51338
22. Bolia R, Srivastava A, Yachha SK, Poddar U. Pediatric CLIF-SOFA score is the best predictor of 28-day mortality
in children with decompensated chronic liver disease. J Hepatol. 2018;68(3):449-455. doi:10.1016/j.jhep.2017.
10.001
23. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in
critically ill patients. JAMA. 2001;286(14):1754-1758. doi:10.1001/jama.286.14.1754
24. Leteurtre S, Duhamel A, Salleron J, Grandbastien B, Lacroix J, Leclerc F; Groupe Francophone de Réanimation
et d’Urgences Pédiatriques (GFRUP). PELOD-2: an update of the Pediatric Logistic Organ Dysfunction score. Crit
Care Med. 2013;41(7):1761-1773. doi:10.1097/CCM.0b013e31828a2bbd
25. Pollack MM, Holubkov R, Funai T, et al; Eunice Kennedy Shriver National Institute of Child Health and Human
Development Collaborative Pediatric Critical Care Research Network. The Pediatric Risk of Mortality score: update
2015. Pediatr Crit Care Med. 2016;17(1):2-9. doi:10.1097/PCC.0000000000000558
26. Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute Physiology and Chronic Health Evaluation (APACHE)
IV: hospital mortality assessment for today’s critically ill patients. Crit Care Med. 2006;34(5):1297-1310. doi:10.
1097/01.CCM.0000215112.84523.F0
27. Zipursky AR, Yoon EW, Emberley J, et al. Central line–associated blood stream infections and non–central line–
associated blood stream infections surveillance in Canadian tertiary care neonatal intensive care units. J Pediatr.
2019;2019(208):176-182.e6. doi:10.1016/j.jpeds.2018.12.011
SUPPLEMENT.
eFigure 1. Cohort Flow Diagram
eTable 1. Microbiologic Isolates From Blood
eFigure 2. nSOFA Component Profiles for Survivors and Nonsurvivors
eTable 2. nSOFA Prognostic Utility for Mortality at Single Centers
eFigure 3. Utility of the Maximum nSOFA Score at Either T0 or T6
eTable 3. nSOFA Scores by Timepoint Among Survivors and Nonsurvivors by Scoring Group
eFigure 4. Likelihood Ratios for Mortality by nSOFA Score Cutoff at T0, T6, T12 and for the nSOFAmax T0, T6
eFigure 5. Performance of nSOFA Among Infants <25 Weeks
eFigure 6. Temporal Progression of nSOFA Scores Among Survivors and Nonsurvivors
eFigure 7. Temporal Progression of Individual Patient nSOFAΔ Dynamics Among Survivors and Nonsurvivors
eFigure 8. Individual Patient-Level Organ Dysfunction Dynamics Among <25 Weeks GA Survivors and
Nonsurvivors
eFigure 9. Prevalence and Temporal Progression of Organ Dysfunction Between Survivors and Nonsurvivors
eFigure 10. nSOFA Scores for Females and Males
eFigure 11. nSOFA Scores by Pathogen Classification
eFigure 12. nSOFA Scores Among Patients With Surgical Peritonitis and Negative Blood Cultures
eAppendix. Neonatal Sequential Organ Failure Assessment (nSOFA)
eReferences

JAMA Network Open. 2021;4(2):e2036518. doi:10.1001/jamanetworkopen.2020.36518 (Reprinted)

Downloaded From: https://jamanetwork.com/ by a Washington University - St Louis User on 02/07/2021

February 4, 2021

11/11

